Published in J Biol Chem on July 26, 1996
Naturally occurring H-DNA-forming sequences are mutagenic in mammalian cells. Proc Natl Acad Sci U S A (2004) 1.57
Muc1 cell surface mucin attenuates epithelial inflammation in response to a common mucosal pathogen. J Biol Chem (2010) 1.16
Methods to determine DNA structural alterations and genetic instability. Methods (2009) 0.90
Characterization of a polypurine/polypyrimidine sequence upstream of the mouse metallothionein-I gene. Nucleic Acids Res (1998) 0.75
Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol (1999) 2.93
DNA bending by asymmetric phosphate neutralization. Science (1994) 2.57
Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. Clin Cancer Res (2001) 2.24
Cloning and sequencing of a human pancreatic tumor mucin cDNA. J Biol Chem (1990) 2.22
Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis and Sjögren's syndrome. Gastroenterology (1996) 2.01
Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut (2003) 2.00
Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia. Br J Cancer (2008) 1.93
Sonic hedgehog paracrine signaling regulates metastasis and lymphangiogenesis in pancreatic cancer. Oncogene (2009) 1.85
Selection and characterization of an RNA decoy for transcription factor NF-kappa B. Biochemistry (1999) 1.77
Substrate specificities of three members of the human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase family, GalNAc-T1, -T2, and -T3. J Biol Chem (1997) 1.72
Tolerance and immunity to MUC1 in a human MUC1 transgenic murine model. Cancer Res (1998) 1.59
Oligosaccharides expressed on MUC1 produced by pancreatic and colon tumor cell lines. J Biol Chem (1997) 1.59
Electrostatic mechanisms of DNA deformation. Annu Rev Biophys Biomol Struct (2000) 1.53
Invasion-specific genes in malignancy: serial analysis of gene expression comparisons of primary and passaged cancers. Cancer Res (2001) 1.49
MUC5B and MUC7 are differentially expressed in mucous and serous cells of submucosal glands in human bronchial airways. Am J Respir Cell Mol Biol (1998) 1.47
A white paper: the product of a pancreas cancer think tank. Cancer Res (2001) 1.39
High levels of ezrin expressed by human pancreatic adenocarcinoma cell lines with high metastatic potential. Biochem Biophys Res Commun (1999) 1.35
Identification of MUC1 proteolytic cleavage sites in vivo. Biochem Biophys Res Commun (2001) 1.34
Cloning of a human UDP-N-acetyl-alpha-D-Galactosamine:polypeptide N-acetylgalactosaminyltransferase that complements other GalNAc-transferases in complete O-glycosylation of the MUC1 tandem repeat. J Biol Chem (1998) 1.34
A regulatory element in intron 1 of the cystic fibrosis transmembrane conductance regulator gene. J Biol Chem (1996) 1.31
Competitive triplex/quadruplex equilibria involving guanine-rich oligonucleotides. Biochemistry (1995) 1.31
Enhanced expression of annexin II in human pancreatic carcinoma cells and primary pancreatic cancers. Carcinogenesis (1993) 1.30
Enhancement of metastatic properties of pancreatic cancer cells by MUC1 gene encoding an anti-adhesion molecule. Int J Cancer (2000) 1.27
The lectin domain of UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-T4 directs its glycopeptide specificities. J Biol Chem (2000) 1.26
The reactive tumor microenvironment: MUC1 signaling directly reprograms transcription of CTGF. Oncogene (2010) 1.23
In vivo recognition of an RNA aptamer by its transcription factor target. Biochemistry (2001) 1.20
Exclusion of RNA strands from a purine motif triple helix. Nucleic Acids Res (1994) 1.19
Specific hybridization arrest of dihydrofolate reductase mRNA in vitro using anti-sense RNA or anti-sense oligonucleotides. Arch Biochem Biophys (1987) 1.13
DNA bending by hexamethylene-tethered ammonium ions. Proc Natl Acad Sci U S A (1996) 1.11
The human homologue of the RNA polymerase II-associated factor 1 (hPaf1), localized on the 19q13 amplicon, is associated with tumorigenesis. Oncogene (2006) 1.11
A novel human UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase, GalNAc-T7, with specificity for partial GalNAc-glycosylated acceptor substrates. FEBS Lett (1999) 1.10
A family of human beta3-galactosyltransferases. Characterization of four members of a UDP-galactose:beta-N-acetyl-glucosamine/beta-nacetyl-galactosamine beta-1,3-galactosyltransferase family. J Biol Chem (1998) 1.10
HMG proteins and DNA flexibility in transcription activation. Mol Cell Biol (2001) 1.10
Human MUC4 mucin cDNA and its variants in pancreatic carcinoma. J Biochem (2000) 1.09
Overexpression of MUC1 reconfigures the binding properties of tumor cells. Int J Cancer (2001) 1.08
Overcoming potassium-mediated triplex inhibition. Nucleic Acids Res (1995) 1.07
Repression of bacteriophage promoters by DNA and RNA oligonucleotides. Nucleic Acids Res (1993) 1.07
Dimensions of feedback in clinical teaching: a descriptive study. Acad Med (1996) 1.07
Molecular cloning and sequence analysis of the human ribosomal protein S16. J Biol Chem (1991) 1.07
MUC4 expression is regulated by cystic fibrosis transmembrane conductance regulator in pancreatic adenocarcinoma cells via transcriptional and post-translational mechanisms. Oncogene (2006) 1.06
Effects of neutralization pattern and stereochemistry on DNA bending by methylphosphonate substitutions. Biochemistry (1997) 1.06
Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth. Oncogene (2011) 1.05
Improved quantitation of DNA curvature using ligation ladders. Nucleic Acids Res (1999) 1.05
Induction of experimental autoimmune sialoadenitis by immunization of PL/J mice with carbonic anhydrase II. J Immunol (1995) 1.02
P-selectin expression in a metastatic pancreatic tumor cell line (SUIT-2). Cancer Res (1997) 1.01
Developmental expression of mucin genes MUC1 and MUC2. J Cell Sci (1994) 1.00
Role of asymmetric phosphate neutralization in DNA bending by PU.1. J Biol Chem (1997) 1.00
Expression of three UDP-N-acetyl-alpha-D-galactosamine:polypeptide GalNAc N-acetylgalactosaminyltransferases in adenocarcinoma cell lines. Cancer Res (1997) 0.99
Control of O-glycan branch formation. Molecular cloning of human cDNA encoding a novel beta1,6-N-acetylglucosaminyltransferase forming core 2 and core 4. J Biol Chem (1999) 0.98
Gonadotropin releasing hormone binding sites in human epithelial ovarian carcinomata. Eur J Cancer Clin Oncol (1989) 0.98
Non-cognitive characteristics of medical students: entry to problem-based and lecture-based curricula. Med Educ (1996) 0.97
CD4+ lymphocytes provide MUC1-specific tumor immunity in vivo that is undetectable in vitro and is absent in MUC1 transgenic mice. J Immunol (1998) 0.97
DNA bending by a phantom protein. Chem Biol (1996) 0.96
The contribution of phosphate-phosphate repulsions to the free energy of DNA bending. Nucleic Acids Res (2005) 0.95
Effect of base composition on DNA bending by phosphate neutralization. Biophys Chem (1998) 0.95
Electrostatic effects in DNA bending by GCN4 mutants. Biochemistry (1998) 0.95
DNA bending by GCN4 mutants bearing cationic residues. Biochemistry (1997) 0.94
Expression of core 2 beta-1,6-N-acetylglucosaminyltransferase in a human pancreatic cancer cell line results in altered expression of MUC1 tumor-associated epitopes. J Biol Chem (1999) 0.93
MUC2 gene expression is found in noninvasive tumors but not in invasive tumors of the pancreas and liver: its close relationship with prognosis of the patients. Hum Pathol (1997) 0.92
Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer. Br J Cancer (2013) 0.92
Molecular adjuvant effects of a conformationally biased agonist of human C5a anaphylatoxin. J Immunol (1997) 0.91
A simple, effective method for the construction of subtracted cDNA libraries. Genet Anal Tech Appl (1991) 0.91
Selection of RNAs that bind to duplex DNA at neutral pH. J Mol Biol (1996) 0.91
Relief of triple-helix-mediated promoter inhibition by elongating RNA polymerases. Nucleic Acids Res (1993) 0.90
MUC4 mucin expression in human pancreatic tumours is affected by organ environment: the possible role of TGFbeta2. Br J Cancer (2004) 0.89
In vivo glycosylation of mucin tandem repeats. Glycobiology (2001) 0.89
The cystic fibrosis transmembrane conductance regulator as a marker of human pancreatic duct development. Gastroenterology (1997) 0.89
Organ-specific pancreatic tumor growth properties and tumor immunity. Cancer Immunol Immunother (1999) 0.88
DNA recognition by alternate strand triple helix formation: affinities of oligonucleotides for a site in the human p53 gene. Biochemistry (1994) 0.88
Design and calibration of a semi-synthetic DNA phasing assay. Nucleic Acids Res (2000) 0.88
Polypeptide core of a human pancreatic tumor mucin antigen. Cancer Res (1990) 0.88
Passively transferred anti-MUC1 antibodies cause neither autoimmune disorders nor immunity against transplanted tumors in MUC1 transgenic mice. Int J Cancer (1999) 0.88
Structural effects of O-glycosylation on a 15-residue peptide from the mucin (MUC1) core protein. Biochemistry (2000) 0.87
Expression of UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase isozymes T1 and T2 in human colorectal cancer. J Gastroenterol (2000) 0.87
Combinatorial selection of a small RNA that induces amplification of IncFII plasmids in Escherichia coli. J Mol Biol (1998) 0.87
Structural analysis of peptide substrates for mucin-type O-glycosylation. Biochemistry (1998) 0.87
Determination of estrogenic/antiestrogenic potential of antifertility substances using rat uterine peroxidase assay. Contraception (1991) 0.86
Thomsen-Friedenreich antigen expression in gastric carcinomas is associated with MUC1 mucin VNTR polymorphism. Glycobiology (2004) 0.86
Experimental evaluation of the Liu-Beveridge dinucleotide step model of DNA structure. Nucleic Acids Res (2001) 0.86
Carbonic anhydrase in human pancreas: hypotheses for the pathophysiological roles of CA isozymes. Ann N Y Acad Sci (1999) 0.86
Searching genomes for sequences with the potential to form intrastrand triple helices. J Mol Biol (2000) 0.86
Recognition of duplex DNA by RNA polynucleotides. Nucleic Acids Res (1995) 0.85
Calcium-activated chloride conductance in a pancreatic adenocarcinoma cell line of ductal origin (HPAF) and in freshly isolated human pancreatic duct cells. Pflugers Arch (1998) 0.85
Stabilities of intrastrand pyrimidine motif DNA and RNA triple helices. Nucleic Acids Res (2000) 0.85
Alteration in expression of MUC2 and MUC3 mRNA levels in HT29 colonic carcinoma cells. Biochem Biophys Res Commun (1994) 0.85
Effects of phosphate neutralization on the shape of the AP-1 transcription factor binding site in duplex DNA. Nucleic Acids Res (1998) 0.85
Preparation of oligonucleotide-biotin conjugates with cleavable linkers. Bioconjug Chem (1995) 0.85
Transfection of the human Muc 1 mucin gene into a poorly differentiated human pancreatic tumor cell line, Panc1: integration, expression and ultrastructural changes. J Cell Sci (1991) 0.84
Altered sensitivity to single-strand-specific reagents associated with the genomic vascular smooth muscle alpha-actin promoter during myofibroblast differentiation. J Biol Chem (2000) 0.84
Relating independent measures of DNA curvature: electrophoretic anomaly and cyclization efficiency. J Biomol Struct Dyn (2000) 0.84
DNA bending by asymmetrically tethered cations: influence of tether flexibility. Chem Biol (2001) 0.83
A nuclear factor that binds purine-rich, single-stranded oligonucleotides derived from S1-sensitive elements upstream of the CFTR gene and the MUC1 gene. Nucleic Acids Res (1994) 0.83
Influence of acceptor substrate primary amino acid sequence on the activity of human UDP-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyltransferase. Studies with the MUC1 tandem repeat. J Biol Chem (1994) 0.83
Influence of organ site and tumor cell type on MUC1-specific tumor immunity. Int Immunol (2001) 0.82
CFTR expression does not influence glycosylation of an epitope-tagged MUC1 mucin in colon carcinoma cell lines. Glycobiology (1999) 0.82
Isolation and characterization of a complementary DNA (PD-1) differentially expressed by human pancreatic ductal cell tumors. Cell Growth Differ (1991) 0.82
Chronic toxicity studies with vasicine from Adhatoda vasica Nees. in rats and monkeys. Indian J Exp Biol (1987) 0.81
The rate of synthesis of glycosaminoglycans and collagen by fibroblasts cultured from adult human liver biopsies. J Clin Invest (1977) 0.81